These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22093812)

  • 1. Pilot assessment of supply chains for pharmaceuticals and medical commodities for malaria, tuberculosis and HIV infection in Ethiopia.
    Daniel G; Tegegnework H; Demissie T; Reithinger R
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):60-2. PubMed ID: 22093812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Global TB Drug Facility: innovative global procurement.
    Kumaresan J; Smith I; Arnold V; Evans P
    Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Health Impact Index: Promoting Global Health.
    Hassoun N
    PLoS One; 2015; 10(12):e0141374. PubMed ID: 26657064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues].
    Kerouedan D
    Bull Soc Pathol Exot; 2010 May; 103(2):119-22. PubMed ID: 20376595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [UNITAID: an innovative and collective financing system for the fight against malaria, AIDS and tuberculosis].
    Simon C; de Lemos G
    Med Trop (Mars); 2006 Dec; 66(6):583-4. PubMed ID: 17286027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.
    Hotez PJ; Molyneux DH; Fenwick A; Ottesen E; Ehrlich Sachs S; Sachs JD
    PLoS Med; 2006 Jan; 3(5):e102. PubMed ID: 16435908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient costs of accessing collaborative tuberculosis and human immunodeficiency virus interventions in Ethiopia.
    Vassall A; Seme A; Compernolle P; Meheus F
    Int J Tuberc Lung Dis; 2010 May; 14(5):604-10. PubMed ID: 20392354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hopes that Novartis deal on tuberculosis will spur donations for HIV and malaria.
    Fleck F
    BMJ; 2004 Jan; 328(7431):70. PubMed ID: 14715592
    [No Abstract]   [Full Text] [Related]  

  • 10. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimalarial drug utilization by women in Ethiopia: a knowledge-attitudes-practice study.
    Yeneneh H; Gyorkos TW; Joseph L; Pickering J; Tedla S
    Bull World Health Organ; 1993; 71(6):763-72. PubMed ID: 8313494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and malaria co-infection: interactions and consequences of chemotherapy.
    Skinner-Adams TS; McCarthy JS; Gardiner DL; Andrews KT
    Trends Parasitol; 2008 Jun; 24(6):264-71. PubMed ID: 18456554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation issues in tuberculosis/HIV program collaboration and integration: 3 case studies.
    Friedland G; Harries A; Coetzee D
    J Infect Dis; 2007 Aug; 196 Suppl 1():S114-23. PubMed ID: 17624820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives.
    Vitoria M; Granich R; Gilks CF; Gunneberg C; Hosseini M; Were W; Raviglione M; De Cock KM
    Am J Clin Pathol; 2009 Jun; 131(6):844-8. PubMed ID: 19461091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early assessment of the implementation of a national programme for the prevention of mother-to-child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities.
    Labhardt ND; Manga E; Ndam M; Balo JR; Bischoff A; Stoll B
    Trop Med Int Health; 2009 Mar; 14(3):288-93. PubMed ID: 19187522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to TB treatment in Ethiopia: why do patients default?
    Tesfaye H
    PLoS Med; 2007 Apr; 4(4):e165. PubMed ID: 17456000
    [No Abstract]   [Full Text] [Related]  

  • 19. Improve tuberculosis services for HIV patients, says WHO.
    Ashraf H
    Lancet; 2003 Jul; 362(9379):218. PubMed ID: 12885508
    [No Abstract]   [Full Text] [Related]  

  • 20. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
    Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.